Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate the Safety, Effectiveness and Impact of the RTS, S/AS01E Vaccine in Young Children in Sub-Saharan Africa

NCT03855995 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03855995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03855995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate the Safety, Effectiveness and Impact of the RTS, S/AS01E Vaccine in Young Children in Sub-Saharan Africa
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 21, 2019
Completion date
August 7, 2025
Enrollment
77,953 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria vaccines